TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Conavi Medical ( (TSE:CNVI) ).
Conavi Medical Corp. announced its participation in the Planet MicroCap Showcase: TORONTO 2025, where CEO Tom Looby will present the company’s advancements on October 22, 2025. This event highlights Conavi’s strategic efforts to engage with investors and stakeholders, potentially enhancing its market presence and attracting investment interest in its innovative cardiovascular imaging technologies.
The most recent analyst rating on (TSE:CNVI) stock is a Buy with a C$1.00 price target. To see the full list of analyst forecasts on Conavi Medical stock, see the TSE:CNVI Stock Forecast page.
More about Conavi Medical
Conavi Medical Corp. is a commercial-stage medical device company that focuses on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures. Their flagship product, the Novasight Hybrid™ System, uniquely combines intravascular ultrasound and optical coherence tomography for simultaneous imaging of coronary arteries. The system has regulatory clearance in the U.S., Canada, China, and Japan.
Average Trading Volume: 31,140
Technical Sentiment Signal: Sell
Current Market Cap: C$34.74M
See more data about CNVI stock on TipRanks’ Stock Analysis page.